Horizon Discovery releases CRISPR screening for primary human B cells
Cambridge, UK-based Horizon Discovery Group, specializing in the application of gene editing and gene modulation for cell line engineering, has released an arrayed CRISPR knockout screening service for primary human B cells to its cell-based screening services. The new B cell screening service, the first of its kind in the market, will enable researchers to […]
